Item 1.01 Entry into a Material Definitive Agreement

On February 4, 2014, Bakken Resources, Inc. (the “Company”) executed and completed the sale of certain of its assets comprised of 767 +/- net mineral acres in McKenzie County, North Dakota (the “Assets”) pursuant to a Purchase and Sale Agreement (“PSA”), whereby the Assets were sold to Athene Annuity & Life Assurance Company (the “Buyer”).  The Assets were sold for $10,250 per net mineral acre for a total of $7,871,248.  In addition, the Company will continue to receive a two percent (2%) royalty based on any proceeds received from oil or gas production on the Assets.  The Assets were purchased by the Company in November 2010 for an aggregate amount of $1,535,000.  The Assets were sold having an effective date of January 1, 2014 for purposes of determining rights to proceeds from the Assets. The PSA evidencing the sale of the Assets contained other customary representations and warranties of the Company and conditions of closing.

Ten percent (10%) of the proceeds from the sale will be escrowed pending title review.

Prior to the sale of the Assets, the Company had no prior relationship with the Buyer.

The foregoing is only a summary of the material provisions of the PSA, it may not contain all of the information that is important to you and it is qualified in its entirety by reference to a redacted version of the PSA itself, which is attached as Exhibit 10.1 hereto and is incorporated herein.

A press release announcing this transaction is included in this Current Report on Form 8-K as Exhibit 99.1.

Item 2.01 Completion of Acquisition of Disposition of Assets

The Information set forth in Item 1.01 regarding the disposition of the Assets is incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits

(d) Exhibits

* The exhibits and schedules to this agreement have been omitted from this filing pursuant to Item 601(b)(2) of Regulation S-K. The Company will furnish copies of such exhibits and schedules to the Securities and Exchange Commission upon request. In addition to filing this Current Report on Form 8-K, the Company intends to file a confidential treatment request with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended, and Rule 24-b2 of the Securities Exchange Act of 1934, as amended, to obtain confidential treatment for certain portions of the PSA.

2